The latest price target for Tenaya Therapeutics (NASDAQ:TNYA) was reported by Chardan Capital on November 7, 2024. The analyst firm set a price target for $18.00 expecting TNYA to rise to within 12 months (a possible 786.70% upside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for Tenaya Therapeutics (NASDAQ:TNYA) was provided by Chardan Capital, and Tenaya Therapeutics maintained their buy rating.

There is no last upgrade for Tenaya Therapeutics

There is no last downgrade for Tenaya Therapeutics.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenaya Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenaya Therapeutics was filed on November 7, 2024 so you should expect the next rating to be made available sometime around November 7, 2025.

While ratings are subjective and will change, the latest Tenaya Therapeutics (TNYA) rating was a maintained with a price target of $20.00 to $18.00. The current price Tenaya Therapeutics (TNYA) is trading at is $2.03, which is out of the analyst’s predicted range.